WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997010217) 4-AZASTEROIDS FOR TREATMENT OF HYPERANDROGENIC CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/010217    International Application No.:    PCT/US1996/014564
Publication Date: 20.03.1997 International Filing Date: 11.09.1996
Chapter 2 Demand Filed:    03.01.1997    
IPC:
A61K 31/435 (2006.01), C07J 73/00 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, NJ 07065 (US) (For All Designated States Except US).
BAKSHI, Raman, K. [IN/US]; (US) (For US Only).
SAHOO, Soumya, P. [IN/US]; (US) (For US Only).
TOLMAN, Richard, L. [US/US]; (US) (For US Only)
Inventors: BAKSHI, Raman, K.; (US).
SAHOO, Soumya, P.; (US).
TOLMAN, Richard, L.; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, NJ 07065 (US)
Priority Data:
60/003,826 15.09.1995 US
9603487.1 20.02.1996 GB
Title (EN) 4-AZASTEROIDS FOR TREATMENT OF HYPERANDROGENIC CONDITIONS
(FR) 4-AZASTEROIDES UTILISES POUR LE TRAITEMENT D'ETATS HYPERANDROGENIQUES
Abstract: front page image
(EN)Compounds of structural Formula (I), and pharmacologically acceptable salts and esters thereof possess 5$g(a)-reductase inhibitory activity. These compounds inhibit 5$g(a)-reductase type 1 and type 2. The compounds of structural Formula (I) are useful in the systemic, including oral, and parenteral, including topical, treatment and prevention of hyperandrogenic conditions including prostatic carcinoma, benign prostatic hyperplasia, acne vulgaris, seborrhea, androgenic alopecia (also called androgenetic alopecia) which includes male- and female-pattern baldness, female hirsutism, and prostatitis. A class of compounds of the present invention are also potent anti-androgens. The present invention also relates to novel compositions containing such compounds, methods of their use and methods of their manufacture.
(FR)L'invention porte sur des composés représentés par la formule développée (I), et sur leurs sels et leurs esters pharmaceutiquement acceptables, possédant une activité inhibitrice de 5$g(a)-réductase. Ces composés inhibent la 5$g(a)-réductase des types 1 et 2. Les composés de formule développée (I) servent au traitement curatif et préventif systémique - y compris oral, et parentéral - y compris local, d'états hyperandrogéniques, y compris de carcinomes prostatiques, de l'hyperplasie prostatique, de l'acné vulgaire, de la séborrhée, de l'alopécie androgénique (également appelée alopécie androgénétique), qui comprend la calvitie masculine et féminime, l'hirsutisme féminin et la prostatite. Des composés de la présente invention sont également de puissants anti-androgènes. L'invention porte également sur des compositions contenant de tels composés, sur leurs procédés d'utilisation et leurs procédés de fabrication.
Designated States: AL, AM, AU, AZ, BA, BB, BG, BR, BY, CA, CN, CU, CZ, EE, GE, HU, IL, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LV, MD, MG, MK, MN, MX, NO, NZ, PL, RO, RU, SG, SI, SK, TJ, TM, TR, TT, UA, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)